Melanie Thiede

478 total citations
15 papers, 364 citations indexed

About

Melanie Thiede is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Melanie Thiede has authored 15 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Immunology and 5 papers in Genetics. Recurrent topics in Melanie Thiede's work include CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (8 papers) and Virus-based gene therapy research (5 papers). Melanie Thiede is often cited by papers focused on CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (8 papers) and Virus-based gene therapy research (5 papers). Melanie Thiede collaborates with scholars based in Germany, Austria and Canada. Melanie Thiede's co-authors include Christian Brandts, Stefan Burdach, Gary J. Schiller, Hubert Serve, Stephen D. Nimer, Frank Breitenbuecher, Francis J. Giles, Stefan Kasper, Thomas Fischer and Richard M. Stone and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Melanie Thiede

14 papers receiving 359 citations

Peers

Melanie Thiede

HEMAT

GENET

ONCOL

IMMUN

Karen Lambie Canada

Doan Le Canada

Ya‐Zhen Qin China

Steve Pavletic United States

Mark D. Ewalt United States

W. M. C. Geertsma-Kleinekoort Netherlands

Alexandra Oltová Czechia

Gurveen Saberwal United States

A Severino Italy

Jon Akutagawa United States

Karen Lambie Canada

Melanie Thiede

237 ×1.2

HEMAT

160 ×1.0

121 ×1.2

GENET

95 ×1.0

ONCOL

65 ×0.8

IMMUN

Citations per year, relative to Melanie Thiede Melanie Thiede (= 1×) peers Karen Lambie

Countries citing papers authored by Melanie Thiede

Since Specialization

Citations

This map shows the geographic impact of Melanie Thiede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Thiede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Thiede more than expected).

Fields of papers citing papers by Melanie Thiede

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Thiede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Thiede. The network helps show where Melanie Thiede may publish in the future.

Co-authorship network of co-authors of Melanie Thiede

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Thiede. A scholar is included among the top collaborators of Melanie Thiede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Thiede. Melanie Thiede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Thiede, Melanie, Leopold Flohé, Valentina Evdokimova, et al.. (2024). Cytokine screening identifies TNF to potentially enhance immunogenicity of pediatric sarcomas. Frontiers in Immunology. 15. 1347404–1347404. 1 indexed citations

Schober, Sebastian Johannes, Melanie Thiede, Julia Hauer, et al.. (2024). TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model. Frontiers in Immunology. 15. 1330868–1330868. 3 indexed citations

Thiel, Uwe, et al.. (2024). YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells. Frontiers in Oncology. 14. 1304374–1304374.

Schober, Sebastian Johannes, Melanie Thiede, Julia Hauer, et al.. (2023). The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma. Clinical Cancer Research. 29(10). 1996–2011. 14 indexed citations

Poorebrahim, Mansour, Melanie Thiede, Kilian Schober, et al.. (2022). T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer. Cancers. 14(22). 5485–5485. 1 indexed citations

Schober, Sebastian Johannes, et al.. (2021). Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing’s Sarcoma, Enhancing T Cell Cytotoxicity. Cells. 10(11). 3070–3070. 5 indexed citations

Evdokimova, Valentina, Peter Ruzanov, Sebastian Johannes Schober, et al.. (2021). Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function. Cells. 10(8). 2081–2081. 22 indexed citations

Schober, Sebastian Johannes, Melanie Thiede, Dirk Wohlleber, et al.. (2020). MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo. Cells. 9(7). 1581–1581. 20 indexed citations

Schober, Sebastian Johannes, Melanie Thiede, Dirk Wohlleber, et al.. (2018). Abstract LB-106: Allorepertoire-derived HLA class I/peptide-specific T cell receptor transgenic CD4+ T cells mediate antitumor responses in Ewing sarcoma mimicking allo-rejection. Cancer Research. 78(13_Supplement). LB–106. 1 indexed citations

10.

Kirschner, A., Melanie Thiede, Thomas G. P. Grünewald, et al.. (2017). Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcomain vitroandin vivo. OncoImmunology. 6(2). e1273301–e1273301. 28 indexed citations

11.

Thiel, Uwe, Sebastian Johannes Schober, Ingo Einspieler, et al.. (2017). Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells. OncoImmunology. 6(5). e1312239–e1312239. 20 indexed citations

12.

Blaeschke, Franziska, Uwe Thiel, A. Kirschner, et al.. (2016). Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growthin vitroandin vivo. Oncotarget. 7(28). 43267–43280. 21 indexed citations

13.

Kirschner, A., Melanie Thiede, Franziska Blaeschke, et al.. (2016). Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens. Oncotarget. 7(35). 56584–56597. 6 indexed citations

14.

Albers, Corinna, Anna Lena Illert, Cornelius Miething, et al.. (2011). An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis. Blood. 118(8). 2200–2210. 11 indexed citations

15.

Heidel, Florian H., Frank Breitenbuecher, Daniel B. Lipka, et al.. (2005). Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood. 107(1). 293–300. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact